Signablok, Inc.

Biotechnology company · Worcester, Massachusetts, United States

Signablok, Inc. is a biotechnology company headquartered in Worcester, Massachusetts, United States. It has received 16 US government small-business research awards (SBIR/STTR) from health agencies, $7.5 million in total, most recently in 2025.

www.signablok.comProfile compiled from public records. Is this your company? Request a correction or update

Signablok at a glance

Typebiotechnology company
HeadquartersWorcester, Massachusetts, United States
Employees (self-reported, 2025)2

What does Signablok do?

US government research funding

16 SBIR/STTR small-business research awards from US health agencies, $7.5 million in total (2012 to 2025). NIH funding came from the National Cancer Institute, National Eye Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Frequently asked questions about Signablok

Where is Signablok headquartered?

Signablok, Inc. is headquartered in Worcester, Massachusetts, United States.

What does Signablok do?

Signablok, Inc. is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences